DK2170050T3 - Korttidsvirkende phenylalkylamin-calciumkanalblokkere og anvendelser deraf - Google Patents

Korttidsvirkende phenylalkylamin-calciumkanalblokkere og anvendelser deraf

Info

Publication number
DK2170050T3
DK2170050T3 DK08768636.6T DK08768636T DK2170050T3 DK 2170050 T3 DK2170050 T3 DK 2170050T3 DK 08768636 T DK08768636 T DK 08768636T DK 2170050 T3 DK2170050 T3 DK 2170050T3
Authority
DK
Denmark
Prior art keywords
short
calcium channel
channel blockers
phenylalkylamine
acting
Prior art date
Application number
DK08768636.6T
Other languages
English (en)
Inventor
Martin P Maguire
Elise Rioux
Harry J Leighton
Original Assignee
Milestone Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milestone Pharmaceuticals Inc filed Critical Milestone Pharmaceuticals Inc
Application granted granted Critical
Publication of DK2170050T3 publication Critical patent/DK2170050T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/43—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK08768636.6T 2007-06-20 2008-06-19 Korttidsvirkende phenylalkylamin-calciumkanalblokkere og anvendelser deraf DK2170050T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93644007P 2007-06-20 2007-06-20
PCT/US2008/007665 WO2008156820A1 (en) 2007-06-20 2008-06-19 Short acting phenylalkylamine calcium channel blockers and uses thereof

Publications (1)

Publication Number Publication Date
DK2170050T3 true DK2170050T3 (da) 2014-09-29

Family

ID=40156562

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08768636.6T DK2170050T3 (da) 2007-06-20 2008-06-19 Korttidsvirkende phenylalkylamin-calciumkanalblokkere og anvendelser deraf

Country Status (19)

Country Link
US (16) US20100190852A1 (da)
EP (1) EP2170050B1 (da)
JP (1) JP5421908B2 (da)
KR (1) KR101541557B1 (da)
CN (1) CN101754678B (da)
AU (1) AU2008266798B2 (da)
BR (1) BRPI0812919B8 (da)
CA (1) CA2693627C (da)
CY (1) CY1115619T1 (da)
DK (1) DK2170050T3 (da)
ES (1) ES2498047T3 (da)
HK (1) HK1140913A1 (da)
HR (1) HRP20140801T1 (da)
MX (1) MX347325B (da)
NZ (1) NZ582033A (da)
PL (1) PL2170050T3 (da)
PT (1) PT2170050E (da)
SI (1) SI2170050T1 (da)
WO (1) WO2008156820A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX347325B (es) 2007-06-20 2017-04-12 Milestone Pharmaceuticals Inc Bloqueadores del canal de calcio de fenilalquilamina de accion corta y sus usos.
KR101052620B1 (ko) * 2008-08-28 2011-07-29 한국과학기술연구원 신규 페닐아세테이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 ｔ-형 칼슘 이온 채널의 활성에 의해 유발되는 질환의 예방 또는 치료용 조성물
PL2482658T3 (pl) * 2009-09-30 2015-10-30 Microdose Therapeutx Inc Sposoby i kompozycje do leczenia objawu Raynauda
WO2015073919A1 (en) * 2013-11-14 2015-05-21 University Medical Pharmaceuticals Corporation Microneedles for therapeutic agent delivery with improved mechanical properties
ME03679B (me) * 2015-04-14 2020-10-20 Milestone Pharmaceuticals Inc Soli kratkodelujućeg fenilalkilamina, bloкatora кalcijumsкih кanala, које su visoko rastvorljive u vodi i njihova primena
EP4119137A1 (en) * 2021-07-15 2023-01-18 Milestone Pharmaceuticals Inc. Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
US3957845A (en) * 1962-04-27 1976-05-18 Knoll A.G. Chemische Fabriken Trifluoromethyl-substituted phenyl acetonitriles
DE1493904A1 (de) * 1965-07-31 1969-06-19 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE2059923C3 (de) * 1970-12-05 1979-01-25 Knoll Ag, 6700 Ludwigshafen l-a-Isopropyl-o-[(N-methyl-N-homoveratryl)v-aminopropyl] -3,4-dimethoxyphenylacetonitril, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
JPS5118940B2 (da) * 1971-12-25 1976-06-14
DE2631222C3 (de) * 1976-07-12 1979-01-04 Knoll Ag, 6700 Ludwigshafen Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE3144150A1 (de) * 1981-04-10 1982-12-09 Basf Ag, 6700 Ludwigshafen (omega)-cyan-1,(omega)-diphenyl-azaalkan-derivate, ihre herstellung und diese enthaltende arzneimittel
DE3433383A1 (de) * 1984-09-12 1986-03-20 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phenyl-acetonitril-derivate
DE3603032A1 (de) * 1986-01-31 1987-08-06 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
US4833162A (en) * 1988-02-03 1989-05-23 American Cyanamid Company Substituted benzeneacetonitriles and their use as calcium channel blockers
US5486539A (en) * 1989-12-21 1996-01-23 G. D. Searle & Co. Method of using phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
IE64870B1 (en) 1989-12-21 1995-09-20 Searle & Co Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppressants and vasodilators
US5162569A (en) 1989-12-21 1992-11-10 G. D. Searle & Co. Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
US5247119A (en) * 1990-12-12 1993-09-21 G. D. Searle & Co. Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
US5451604A (en) * 1993-07-26 1995-09-19 G. D. Searle & Co. Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives
US5910601A (en) * 1994-09-26 1999-06-08 Darwin Discovery Limited Chiral nitriles, their preparation and their use for the manufacture of verapamil and analogues
US5859279A (en) 1996-09-10 1999-01-12 Darwin Discovery Limited Compound and process
US6750238B1 (en) 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US7511077B2 (en) * 2005-02-09 2009-03-31 Neuromed Pharmaceuticals Ltd. Diamine calcium channel blockers
GB2435824A (en) 2006-03-09 2007-09-12 Esteve Labor Dr Use of nitrile compounds in the treatment of food related and other disorders
MX347325B (es) 2007-06-20 2017-04-12 Milestone Pharmaceuticals Inc Bloqueadores del canal de calcio de fenilalquilamina de accion corta y sus usos.

Also Published As

Publication number Publication date
EP2170050B1 (en) 2014-06-18
CA2693627A1 (en) 2008-12-24
US20140296335A1 (en) 2014-10-02
HRP20140801T1 (hr) 2014-11-21
PL2170050T3 (pl) 2014-12-31
AU2008266798B2 (en) 2014-07-17
US20210059972A1 (en) 2021-03-04
US20170312242A1 (en) 2017-11-02
CY1115619T1 (el) 2017-01-04
KR101541557B1 (ko) 2015-08-03
BRPI0812919A2 (pt) 2014-10-07
EP2170050A4 (en) 2010-11-24
US20180280339A1 (en) 2018-10-04
CN101754678B (zh) 2014-04-16
CN101754678A (zh) 2010-06-23
MX2009014052A (es) 2010-03-01
WO2008156820A1 (en) 2008-12-24
JP5421908B2 (ja) 2014-02-19
US9463179B2 (en) 2016-10-11
KR20100043175A (ko) 2010-04-28
US20240115543A1 (en) 2024-04-11
HK1140913A1 (en) 2010-10-29
BRPI0812919B8 (pt) 2021-05-25
ES2498047T3 (es) 2014-09-24
US20160374982A1 (en) 2016-12-29
US20220142963A1 (en) 2022-05-12
US20190380993A1 (en) 2019-12-19
US20210315855A1 (en) 2021-10-14
AU2008266798A1 (en) 2008-12-24
US20200230097A1 (en) 2020-07-23
US9737503B2 (en) 2017-08-22
CA2693627C (en) 2016-01-12
SI2170050T1 (sl) 2014-12-31
MX347325B (es) 2017-04-12
JP2010530429A (ja) 2010-09-09
US20100190852A1 (en) 2010-07-29
US20170312241A1 (en) 2017-11-02
US20190142781A1 (en) 2019-05-16
US10010522B2 (en) 2018-07-03
US20160074354A1 (en) 2016-03-17
US9227918B2 (en) 2016-01-05
US10010523B2 (en) 2018-07-03
NZ582033A (en) 2012-07-27
US20230255923A1 (en) 2023-08-17
US10010524B2 (en) 2018-07-03
EP2170050A1 (en) 2010-04-07
US20170312243A1 (en) 2017-11-02
BRPI0812919B1 (pt) 2019-01-29
PT2170050E (pt) 2014-09-04

Similar Documents

Publication Publication Date Title
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
BRPI0812509A2 (pt) Aparelho reformador e método
BRPI0807225A2 (pt) Dispositivo e método endocirúrgico
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
DK2185552T3 (da) Dipeptoid-prodrugs og anvendelse heraf
DK2349430T3 (da) KATETERISERINGANORDNING og -kit
DK3338790T3 (da) Oligopeptid-forbindelser og anvendelser deraf
BRPI0814324A2 (pt) Dispositivo
BRPI0822034A2 (pt) Dispositivo
BRPI0816907A2 (pt) Método e dispositivo
DK3092901T3 (da) Quinolonanaloger og fremgangsmåder relateret dertil
DK2268562T3 (da) Shuttlestation og shuttle-kanallager
DE602008001096D1 (de) Wälzlagervorrichtung
FI20075686A0 (fi) Konfigurointimenetelmä ja -laite
DE502008001742D1 (de) Kabelbearbeitungseinrichtung
DK2170050T3 (da) Korttidsvirkende phenylalkylamin-calciumkanalblokkere og anvendelser deraf
NO20075424L (no) Fremgangsmate og anvendelse
DK2307389T3 (da) Dibenzothiazepinderivat og anvendelser deraf
DK2310037T3 (da) Conglutin-gamma as-medikament og -kosttilskudpatentkrav
DE112008004261A5 (de) Schichtabscheidevorrichtung und Schichtabscheideverfahren
EE00833U1 (et) Personaalne haloteraapiaseade
DE102008019631B8 (de) Gleitbauteil
SE0702098L (sv) Hållaranordning
MA28867B1 (fr) Echantillonneur
UA15442S (uk) Профіль